DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
GALLOPAMIL
2
Small molecule
Investigational
Unknown
Unknown
Asthma; Cardiovascular Diseases
Unknown
GALLOPAMIL
×
Maximum Phase:
2
First Approval:
None
UNII:
39WPC8JHR8
Molecule Type:
Small molecule
Molecular Formula:
C28H40N2O5
Molecular Weight:
484.64
AlogP:
5.1
PSA:
73.18
HBD:
0.0
HBA:
#RotB:
14.0
Source:
AMLISIMOD
2
Protein
Investigational
Unknown
Unknown
Dry Eye Syndromes
Unknown
AMLISIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
UPAMOSTAT
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Severe Acute Respiratory Syndrome
Unknown
UPAMOSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
S5M7KW6U17
Molecule Type:
Small molecule
Molecular Formula:
C32H47N5O6S
Molecular Weight:
629.82
AlogP:
4.34
PSA:
154.63
HBD:
3.0
HBA:
#RotB:
11.0
Source:
KELIXIMAB
2
Antibody
Investigational
Unknown
Unknown
Unknown
T-cell surface antigen CD4 negative modulator
KELIXIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SIMUFILAM
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Unknown
SIMUFILAM
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C15H21N3O
Molecular Weight:
259.35
AlogP:
1.04
PSA:
35.58
HBD:
1.0
HBA:
#RotB:
2.0
Source:
LY2245461
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Estrogen receptor modulator
LY2245461
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-906024
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Breast Neoplasms; Carcinoma, Adenoid Cystic
Unknown
BMS-906024
×
Maximum Phase:
2
First Approval:
None
UNII:
DRL23N424R
Molecule Type:
Small molecule
Molecular Formula:
C26H26F6N4O3
Molecular Weight:
556.51
AlogP:
4.35
PSA:
104.86
HBD:
2.0
HBA:
#RotB:
9.0
Source:
GENISTEIN
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Colorectal Neoplasms; Cystic Fibrosis; Neoplasms; Rectal Neoplasms; Breast Neoplasms; Coronary Disease; Metabolic Syndrome; Osteoporosis; Pancreatic Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Pulmonary Fibrosis; Urinary Bladder Neoplasms
Unknown
GENISTEIN
×
Maximum Phase:
2
First Approval:
None
UNII:
DH2M523P0H
Molecule Type:
Small molecule
Molecular Formula:
C15H10O5
Molecular Weight:
270.24
AlogP:
2.58
PSA:
90.9
HBD:
3.0
HBA:
#RotB:
1.0
Source:
LABETUZUMAB
2
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Colonic Neoplasms; Colorectal Neoplasms; Pancreatic Neoplasms; Rectal Neoplasms
Carcinoembryonic antigen-related cell adhesion molecule 5 other
LABETUZUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
EFE6X5M3UY
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MAVELERTINIB
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Epidermal growth factor receptor erbB1 inhibitor
MAVELERTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
YXX2180047
Molecule Type:
Small molecule
Molecular Formula:
C18H22FN9O2
Molecular Weight:
415.43
AlogP:
0.68
PSA:
115.02
HBD:
2.0
HBA:
#RotB:
6.0
Source:
LERIDISTIM
2
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
LERIDISTIM
×
Maximum Phase:
2
First Approval:
None
UNII:
WYY7RA43DK
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ELUBRIXIN
2
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive; Colitis, Ulcerative; Cystic Fibrosis
Interleukin-8 receptor B antagonist
ELUBRIXIN
×
Maximum Phase:
2
First Approval:
None
UNII:
MW2AIJ8USP
Molecule Type:
Small molecule
Molecular Formula:
C17H17Cl2FN4O4S
Molecular Weight:
463.32
AlogP:
3.08
PSA:
110.77
HBD:
4.0
HBA:
#RotB:
4.0
Source:
RELCOVAPTAN
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Oxytocin receptor antagonist
RELCOVAPTAN
×
Maximum Phase:
2
First Approval:
None
UNII:
C1GL8G6G0O
Molecule Type:
Small molecule
Molecular Formula:
C28H27Cl2N3O7S
Molecular Weight:
620.51
AlogP:
3.3
PSA:
139.47
HBD:
2.0
HBA:
#RotB:
7.0
Source:
VANUTIDE CRIDIFICAR
2
Protein
Investigational
Unknown
Unknown
Alzheimer Disease
Beta amyloid A4 protein vaccine antigen
VANUTIDE CRIDIFICAR
×
Maximum Phase:
2
First Approval:
None
UNII:
9HRI13ZIDX
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CP-778875
2
Small molecule
Investigational
Unknown
Unknown
Lipid Metabolism Disorders
Peroxisome proliferator-activated receptor alpha agonist
CP-778875
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-232798
2
Small molecule
Investigational
Unknown
Unknown
HIV Infections
C-C chemokine receptor type 5 inhibitor
PF-232798
×
Maximum Phase:
2
First Approval:
None
UNII:
63P7W7886U
Molecule Type:
Small molecule
Molecular Formula:
C29H40FN5O2
Molecular Weight:
509.67
AlogP:
4.31
PSA:
70.47
HBD:
1.0
HBA:
#RotB:
7.0
Source:
RIMTUZALCAP
2
Small molecule
Investigational
Unknown
Unknown
Essential Tremor
Unknown
RIMTUZALCAP
×
Maximum Phase:
2
First Approval:
None
UNII:
USO2D5J77R
Molecule Type:
Small molecule
Molecular Formula:
C18H24F2N6O
Molecular Weight:
378.43
AlogP:
2.8
PSA:
68.1
HBD:
1.0
HBA:
#RotB:
4.0
Source:
DENAGLIPTIN
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
DENAGLIPTIN
×
Maximum Phase:
2
First Approval:
None
UNII:
DOS9ZOT21L
Molecule Type:
Small molecule
Molecular Formula:
C20H18F3N3O
Molecular Weight:
373.38
AlogP:
2.89
PSA:
70.12
HBD:
1.0
HBA:
#RotB:
4.0
Source:
LADOSTIGIL
2
Small molecule
Investigational
Unknown
Unknown
Dementia
Unknown
LADOSTIGIL
×
Maximum Phase:
2
First Approval:
None
UNII:
SW3H1USR4Q
Molecule Type:
Small molecule
Molecular Formula:
C16H20N2O2
Molecular Weight:
272.35
AlogP:
2.35
PSA:
41.57
HBD:
1.0
HBA:
#RotB:
4.0
Source:
EDRALBRUTINIB
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Neuromyelitis Optica
Unknown
EDRALBRUTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C26H21F2N5O3
Molecular Weight:
489.48
AlogP:
3.84
PSA:
106.24
HBD:
2.0
HBA:
#RotB:
4.0
Source:
FE 202767
2
Protein
Investigational
Unknown
Unknown
Premature Birth
Oxytocin receptor agonist
FE 202767
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BI-811283
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Leukemia, Myeloid, Acute
Serine/threonine-protein kinase Aurora-B inhibitor
BI-811283
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRX0014
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TRX0014
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SDX-101
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Multiple Myeloma
Retinoid X receptor alpha modulator
SDX-101
×
Maximum Phase:
2
First Approval:
None
UNII:
Y1RAH31T6K
Molecule Type:
Small molecule
Molecular Formula:
C17H21NO3
Molecular Weight:
287.36
AlogP:
3.38
PSA:
62.32
HBD:
2.0
HBA:
#RotB:
4.0
Source:
MSB0011359C
2
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
MSB0011359C
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
R-348
2
Small molecule
Investigational
Unknown
Unknown
Dry Eye Syndromes; Graft vs Host Disease
Tyrosine-protein kinase JAK3 inhibitor
R-348
×
Maximum Phase:
2
First Approval:
None
UNII:
3J396119JY
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LUCANTHONE HYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Glioblastoma
Unknown
LUCANTHONE HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
918K9N56QZ
Molecule Type:
Small molecule
Molecular Formula:
C20H25ClN2OS
Molecular Weight:
376.95
AlogP:
4.48
PSA:
32.34
HBD:
1.0
HBA:
#RotB:
6.0
Source:
LJN452
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LJN452
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SERALUTINIB
2
Small molecule
Investigational
Unknown
Unknown
Hypertension, Pulmonary
Unknown
SERALUTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C27H27N5O3
Molecular Weight:
469.55
AlogP:
5.29
PSA:
98.26
HBD:
2.0
HBA:
#RotB:
8.0
Source:
IBODUTANT
2
Small molecule
Investigational
Unknown
Unknown
Irritable Bowel Syndrome
Neurokinin 2 receptor antagonist
IBODUTANT
×
Maximum Phase:
2
First Approval:
None
UNII:
1H7RSQ28BJ
Molecule Type:
Small molecule
Molecular Formula:
C37H48N4O4S
Molecular Weight:
644.88
AlogP:
5.23
PSA:
99.77
HBD:
3.0
HBA:
#RotB:
11.0
Source:
DP001
2
Small molecule
Investigational
Unknown
Unknown
Osteoporosis, Postmenopausal; Hyperparathyroidism, Secondary; Osteoporosis
Vitamin D receptor agonist
DP001
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C27H44O3
Molecular Weight:
416.65
AlogP:
5.7
PSA:
60.69
HBD:
3.0
HBA:
#RotB:
6.0
Source:
NESVACUMAB
2
Antibody
Investigational
Unknown
Unknown
Neoplasms; Macular Degeneration
Angiopoietin-2 inhibitor
NESVACUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
WX8293WGLC
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TOL101
2
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
TOL101
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GAMMA TOCOPHEROL
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
GAMMA TOCOPHEROL
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMA0076
2
Small molecule
Investigational
Unknown
Unknown
Glaucoma; Ocular Hypertension
Rho-associated protein kinase inhibitor
AMA0076
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
169
170
171
172
173
174
175
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA